Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.33 trillion and total revenue of $115.96 billion.
Market Cap
1.33T
Revenue
115.96B
Profits
-37.98B
PE Ratio
n/a
Profit Margin
-32.75%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 130.53B | 0.84% | 1,386,645 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 80.27B | 0.72% | 600,266 | 15.53B |
| 3 | MRNA | Moderna, Inc. | 72.88B | 5.56% | 24,033,888 | 2.23B |
| 4 | ARGX | argenx SE | 61.21B | -2.47% | 304,470 | 5.32B |
| 5 | ONC | BeOne Medicines AG | 41.85B | 0.66% | 262,934 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 41.34B | 0.05% | 1,882,365 | - |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 33.67B | 3.00% | 1,131,953 | 4.80B |
| 8 | RPRX | Royalty Pharma plc | 33.65B | 0.14% | 2,691,704 | 2.54B |
| 9 | ROIV | Roivant Sciences Ltd. | 27.61B | -1.97% | 6,752,769 | 7.53M |
| 10 | INSM | Insmed Incorporated | 26.38B | -0.15% | 2,405,271 | 1.14B |
| 11 | INCY | Incyte Corporation | 25.73B | 1.83% | 1,647,177 | 5.82B |
| 12 | BNTX | BioNTech SE | 25.34B | 2.93% | 1,050,807 | 3.03B |
| 13 | GMAB | Genmab A/S | 20.84B | 1.53% | 2,297,612 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 15.62B | -0.37% | 482,010 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 15.60B | -0.01% | 548,315 | 1.20B |
| 16 | EXEL | Exelixis, Inc. | 14.41B | 1.63% | 1,860,284 | 2.44B |
| 17 | SMMT | Summit Therapeutics Inc. | 13.66B | 1.30% | 4,617,161 | - |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.53B | 3.98% | 3,782,987 | 713.07M |
| 19 | HALO | Halozyme Therapeutics, Inc. | 13.07B | 3.30% | 4,151,542 | 1.66B |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.70B | 3.29% | 810,250 | 830.81M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 12.27B | -1.08% | 1,962,554 | 3.41B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.99B | -0.60% | 266,075 | 1.28B |
| 23 | TECH | Bio-Techne Corporation | 11.38B | 0.11% | 3,441,497 | 1.22B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 10.64B | -1.16% | 299,785 | 776.57M |
| 25 | KRYS | Krystal Biotech, Inc. | 10.39B | 5.10% | 274,575 | 440.48M |
| 26 | TWST | Twist Bioscience Corporation | 10.32B | -0.74% | 2,314,632 | 431.80M |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.15B | 4.46% | 3,115,925 | 669.50M |
| 28 | KYMR | Kymera Therapeutics, Inc. | 10.15B | 3.73% | 779,427 | 105.00M |
| 29 | IBRX | ImmunityBio, Inc. | 9.85B | 9.94% | 21,133,175 | 165.79M |
| 30 | CYTK | Cytokinetics, Incorporated | 9.40B | 0.04% | 2,388,591 | 67.67M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 9.39B | 0.06% | 806,176 | 281.99M |
| 32 | CAI | Caris Life Sciences, Inc. | 8.89B | 2.68% | 5,959,730 | 989.61M |
| 33 | PCVX | Vaxcyte, Inc. | 8.78B | 0.17% | 1,282,657 | - |
| 34 | ABVX | ABIVAX Société Anonyme | 8.62B | -4.99% | 2,531,681 | 5.33M |
| 35 | PRAX | Praxis Precision Medicines, Inc. | 8.39B | 0.60% | 570,239 | 7.46M |
| 36 | TGTX | TG Therapeutics, Inc. | 8.24B | 1.66% | 2,084,661 | 799.54M |
| 37 | SYRE | Spyre Therapeutics, Inc. | 8.11B | -0.07% | 1,223,437 | - |
| 38 | IMVT | Immunovant, Inc. | 7.70B | 0.30% | 2,255,234 | - |
| 39 | IONS | Ionis Pharmaceuticals, Inc. | 7.60B | 1.89% | 4,236,217 | 874.09M |
| 40 | BLTE | Belite Bio, Inc | 7.06B | 1.12% | 204,650 | - |
| 41 | CGON | CG Oncology, Inc. | 6.89B | -0.65% | 1,641,916 | 6.23M |
| 42 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.83B | 0.45% | 499,891 | 239.92M |
| 43 | ORKA | Oruka Therapeutics, Inc. | 6.26B | 1.25% | 1,055,119 | - |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.23B | 6.29% | 3,748,565 | - |
| 45 | LGND | Ligand Pharmaceuticals Incorporated | 5.95B | 2.91% | 308,766 | 290.54M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 5.93B | -0.66% | 775,171 | 618.07M |
| 47 | CRSP | CRISPR Therapeutics AG | 5.71B | 1.20% | 2,083,545 | 13.39M |
| 48 | TVTX | Travere Therapeutics, Inc. | 5.68B | -4.10% | 3,120,226 | 591.33M |
| 49 | COGT | Cogent Biosciences, Inc. | 5.66B | 1.97% | 2,036,175 | - |
| 50 | PTCT | PTC Therapeutics, Inc. | 5.51B | 1.07% | 1,307,236 | 1.01B |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 5.50B | 1.95% | 1,126,843 | 1.90M |
| 52 | ERAS | Erasca, Inc. | 5.44B | 3.39% | 4,766,264 | - |
| 53 | DFTX | Definium Therapeutics, Inc. | 5.42B | 2.65% | 1,753,534 | - |
| 54 | MANE | Veradermics, Incorporated | 4.94B | 4.73% | 2,137,210 | - |
| 55 | EWTX | Edgewise Therapeutics, Inc. | 4.83B | -0.29% | 2,091,254 | - |
| 56 | IOVA | Iovance Biotherapeutics, Inc. | 4.82B | 4.42% | 16,058,203 | 324.97M |
| 57 | VKTX | Viking Therapeutics, Inc. | 4.77B | 35.67% | 41,227,643 | - |
| 58 | PBLS | Parabilis Medicines, Inc. | 4.72B | 3.36% | 865,553 | 148.00K |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 4.55B | 0.04% | 1,472,450 | 1.14B |
| 60 | TNGX | Tango Therapeutics, Inc. | 4.30B | 14.33% | 6,968,726 | 53.81M |
| 61 | RLAY | Relay Therapeutics, Inc. | 4.24B | 6.38% | 3,632,195 | 10.35M |
| 62 | CELC | Celcuity Inc. | 4.12B | 0.12% | 540,312 | - |
| 63 | ABCL | AbCellera Biologics Inc. | 4.10B | -0.08% | 4,285,265 | 66.17M |
| 64 | TLX | Telix Pharmaceuticals Limited | 4.05B | 5.66% | 613,710 | 890.79M |
| 65 | IDYA | IDEAYA Biosciences, Inc. | 3.83B | 2.19% | 745,787 | 234.13M |
| 66 | XENE | Xenon Pharmaceuticals Inc. | 3.79B | 0.26% | 2,348,206 | 7.50M |
| 67 | LEGN | Legend Biotech Corporation | 3.61B | 0.59% | 2,308,514 | 1.27B |
| 68 | ELVN | Enliven Therapeutics, Inc. | 3.53B | -1.39% | 1,213,440 | - |
| 69 | ARQT | Arcutis Biotherapeutics, Inc. | 3.49B | 7.01% | 2,857,941 | 463.98M |
| 70 | DNLI | Denali Therapeutics Inc. | 3.45B | 5.52% | 2,336,643 | 3.60M |
| 71 | RCUS | Arcus Biosciences, Inc. | 3.42B | 3.55% | 1,385,299 | 117.00M |
| 72 | TARS | Tarsus Pharmaceuticals, Inc. | 3.38B | -0.49% | 517,016 | 606.33M |
| 73 | DYN | Dyne Therapeutics, Inc. | 3.20B | 0.12% | 2,626,972 | - |
| 74 | QURE | uniQure N.V. | 3.14B | 2.19% | 1,145,200 | 18.67M |
| 75 | MBX | MBX Biosciences, Inc. | 2.98B | 1.71% | 433,368 | - |
| 76 | ZLAB | Zai Lab Limited | 2.96B | -0.08% | 996,561 | 449.61M |
| 77 | IMNM | Immunome, Inc. | 2.92B | 2.71% | 1,064,518 | 4.02M |
| 78 | PGEN | Precigen, Inc. | 2.82B | 2.47% | 5,329,027 | 85.72M |
| 79 | NAMS | NewAmsterdam Pharma Company N.V. | 2.79B | 3.28% | 2,869,259 | 7.12M |
| 80 | NRIX | Nurix Therapeutics, Inc. | 2.66B | 1.02% | 1,509,644 | 36.77M |
| 81 | GPCR | Structure Therapeutics Inc. | 2.63B | 0.27% | 612,097 | - |
| 82 | CLDX | Celldex Therapeutics, Inc. | 2.63B | -11.56% | 12,888,897 | 158.00K |
| 83 | IRON | Disc Medicine, Inc. | 2.63B | -0.01% | 450,837 | - |
| 84 | VERA | Vera Therapeutics, Inc. | 2.61B | 5.87% | 1,977,684 | - |
| 85 | MLYS | Mineralys Therapeutics, Inc. | 2.60B | 3.85% | 849,455 | - |
| 86 | BEAM | Beam Therapeutics Inc. | 2.59B | 2.65% | 1,988,519 | 156.04M |
| 87 | VRDN | Viridian Therapeutics, Inc. | 2.51B | 2.50% | 1,456,774 | 71.13M |
| 88 | PHVS | Pharvaris N.V. | 2.47B | -2.28% | 588,602 | - |
| 89 | SLS | SELLAS Life Sciences Group, Inc. | 2.43B | 5.72% | 5,970,417 | - |
| 90 | HRMY | Harmony Biosciences Holdings, Inc. | 2.42B | -1.35% | 577,958 | 959.90M |
| 91 | OCUL | Ocular Therapeutix, Inc. | 2.31B | 5.11% | 2,495,301 | 52.06M |
| 92 | PVLA | Palvella Therapeutics, Inc. | 2.28B | 3.08% | 276,629 | - |
| 93 | BHVN | Biohaven Ltd. | 2.24B | 4.43% | 2,432,650 | - |
| 94 | GENB | Generate Biomedicines, Inc. | 2.24B | 0.46% | 1,306,283 | 26.48M |
| 95 | AUPH | Aurinia Pharmaceuticals Inc. | 2.22B | 0.36% | 885,011 | 311.51M |
| 96 | SRPT | Sarepta Therapeutics, Inc. | 2.20B | 3.33% | 2,193,201 | 1.97B |
| 97 | ADMA | ADMA Biologics, Inc. | 2.20B | 3.15% | 2,737,633 | 512.28M |
| 98 | RXRX | Recursion Pharmaceuticals, Inc. | 2.17B | 2.02% | 40,460,440 | 54.86M |
| 99 | TRVI | Trevi Therapeutics, Inc. | 2.17B | 2.35% | 1,232,819 | - |
| 100 | ZBIO | Zenas BioPharma, Inc. | 2.15B | 1.54% | 452,811 | 1.00M |
| 101 | NUVB | Nuvation Bio Inc. | 2.14B | 0.49% | 4,323,989 | 169.90M |
| 102 | KOD | Kodiak Sciences Inc. | 2.12B | 4.26% | 1,038,378 | - |
| 103 | URGN | UroGen Pharma Ltd. | 2.09B | -1.02% | 394,648 | 188.73M |
| 104 | AGIO | Agios Pharmaceuticals, Inc. | 2.09B | 3.00% | 1,170,410 | 98.34M |
| 105 | NKTR | Nektar Therapeutics | 2.08B | -8.78% | 3,318,137 | 54.59M |
| 106 | VCEL | Vericel Corporation | 2.06B | 1.69% | 546,957 | 306.30M |
| 107 | MESO | Mesoblast Limited | 2.01B | 2.84% | 198,533 | 120.25M |
| 108 | RAPP | Rapport Therapeutics, Inc. | 1.99B | 4.56% | 900,214 | 20.00M |
| 109 | LKFT | Lakefront Biotherapeutics NV | 1.96B | 2.03% | 451,838 | 1.13B |
| 110 | ZYME | Zymeworks Inc. | 1.96B | 2.82% | 446,027 | 37.13M |
| 111 | VIR | Vir Biotechnology, Inc. | 1.95B | 5.70% | 1,852,670 | 303.23M |
| 112 | FTRE | Fortrea Holdings Inc. | 1.94B | 2.05% | 1,509,238 | 2.68B |
| 113 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.94B | 4.04% | 1,570,988 | 208.78M |
| 114 | GHRS | GH Research PLC | 1.91B | -0.25% | 101,620 | - |
| 115 | SEPN | Septerna, Inc. | 1.88B | 4.77% | 412,056 | 98.88M |
| 116 | STOK | Stoke Therapeutics, Inc. | 1.88B | 4.10% | 527,225 | 27.59M |
| 117 | XNCR | Xencor, Inc. | 1.87B | 0.52% | 1,223,605 | 104.97M |
| 118 | ABSI | Absci Corporation | 1.84B | 9.06% | 8,366,973 | 1.56M |
| 119 | COAG | Hemab Therapeutics Holdings, Inc. | 1.79B | 0.74% | 550,080 | - |
| 120 | NVAX | Novavax, Inc. | 1.79B | 4.03% | 7,580,685 | 413.80M |
| 121 | NTLA | Intellia Therapeutics, Inc. | 1.78B | 3.85% | 3,921,412 | 59.51M |
| 122 | TYRA | Tyra Biosciences, Inc. | 1.76B | -0.31% | 1,215,889 | - |
| 123 | NBTX | Nanobiotix S.A. | 1.76B | 1.88% | 44,017 | 38.27M |
| 124 | TSHA | Taysha Gene Therapies, Inc. | 1.68B | 2.38% | 2,305,666 | 5.49M |
| 125 | IMCR | Immunocore Holdings plc | 1.67B | 0.75% | 281,254 | 430.78M |
| 126 | KLRA | Kailera Therapeutics, Inc. | 1.66B | 6.67% | 1,230,034 | - |
| 127 | INBX | Inhibrx Biosciences, Inc. | 1.63B | -1.22% | 292,151 | 1.30M |
| 128 | SNDX | Syndax Pharmaceuticals, Inc. | 1.62B | 0.64% | 1,674,684 | 252.25M |
| 129 | ANAB | AnaptysBio, Inc. | 1.61B | -1.82% | 755,772 | 106.09M |
| 130 | KRSA | Korsana Biosciences, Inc. | 1.59B | 5.33% | 26,625 | - |
| 131 | MAZE | Maze Therapeutics, Inc. | 1.58B | 26.75% | 3,568,200 | 20.00M |
| 132 | KARD | Kardigan, Inc. | 1.54B | 0.86% | 598,212 | - |
| 133 | RARE | Ultragenyx Pharmaceutical Inc. | 1.53B | 6.59% | 8,134,200 | 717.00M |
| 134 | OMER | Omeros Corporation | 1.52B | 13.85% | 3,958,755 | 38.42M |
| 135 | INVA | Innoviva, Inc. | 1.52B | -0.29% | 931,643 | 440.00M |
| 136 | BRVE | Braveheart Bio, Inc. | 1.52B | -5.64% | 829,452 | - |
| 137 | BCAX | Bicara Therapeutics Inc. | 1.51B | 3.50% | 622,174 | - |
| 138 | AVBP | ArriVent BioPharma, Inc. | 1.50B | 1.95% | 389,123 | - |
| 139 | AAPG | Ascentage Pharma Group International | 1.47B | 0.06% | 823 | 94.61M |
| 140 | TRAX | First Tracks Biotherapeutics, Inc. | 1.47B | 5.23% | 893,221 | - |
| 141 | AVLN | Avalyn Pharma Inc. | 1.44B | 2.62% | 233,278 | - |
| 142 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | 6.55% | 1,157,585 | - |
| 143 | DRTS | Alpha Tau Medical Ltd. | 1.40B | -2.32% | 360,468 | - |
| 144 | CGEM | Cullinan Therapeutics, Inc. | 1.39B | 1.50% | 831,812 | - |
| 145 | DMRA | Damora Therapeutics, Inc. | 1.38B | -1.93% | 355,237 | - |
| 146 | LTGO | Latigo Biotherapeutics, Inc. | 1.38B | -1.37% | 418,845 | - |
| 147 | LBRX | LB Pharmaceuticals Inc | 1.38B | -0.70% | 244,402 | - |
| 148 | SVRA | Savara Inc. | 1.35B | -2.75% | 1,414,020 | - |
| 149 | VOR | Vor Biopharma Inc. | 1.30B | 0.50% | 2,586,521 | - |
| 150 | REPL | Replimune Group, Inc. | 1.27B | 4.66% | 1,529,918 | - |
| 151 | AKTS | Aktis Oncology, Inc. | 1.23B | 3.17% | 302,013 | 10.06M |
| 152 | IMTX | Immatics N.V. | 1.21B | 1.72% | 501,599 | 47.65M |
| 153 | ANRO | Alto Neuroscience, Inc. | 1.21B | 0.49% | 347,074 | - |
| 154 | SPTX | Seaport Therapeutics, Inc. | 1.20B | 6.01% | 146,461 | - |
| 155 | MGTX | MeiraGTx Holdings plc | 1.19B | -5.58% | 1,439,344 | 397.50M |
| 156 | MLTX | MoonLake Immunotherapeutics | 1.14B | 6.61% | 2,362,181 | - |
| 157 | CRVS | Corvus Pharmaceuticals, Inc. | 1.13B | 8.21% | 806,628 | - |
| 158 | MNKD | MannKind Corporation | 1.12B | -0.29% | 16,303,712 | 393.63M |
| 159 | ODTX | Odyssey Therapeutics, Inc. | 1.12B | 1.21% | 555,205 | 99.00K |
| 160 | GLUE | Monte Rosa Therapeutics, Inc. | 1.07B | 2.77% | 1,212,988 | 28.73M |
| 161 | ANL | Adlai Nortye Group Ltd. | 1.07B | 6.62% | 107,180 | 18.06M |
| 162 | JANX | Janux Therapeutics, Inc. | 1.07B | 2.70% | 908,285 | 24.00M |
| 163 | JBIO | Jade Biosciences, Inc. | 1.07B | 0.12% | 643,920 | - |
| 164 | APMD | Apnimed, Inc. | 1.06B | -2.71% | 624,121 | 115.12M |
| 165 | OBX | Obsidian Therapeutics, Inc. | 1.05B | -1.90% | 1,151,578 | - |
| 166 | ALMS | Alumis Inc. | 1.05B | 2.66% | 2,524,710 | 7.40M |
| 167 | KURA | Kura Oncology, Inc. | 1.04B | 1.12% | 1,681,020 | 77.23M |
| 168 | HELP | Cybin Inc. | 1.00B | 0.37% | 2,427,671 | - |
| 169 | SANA | Sana Biotechnology, Inc. | 996.87M | 7.42% | 7,169,600 | - |
| 170 | ABUS | Arbutus Biopharma Corporation | 991.22M | 0.20% | 10,494,040 | 181.72M |
| 171 | LXRX | Lexicon Pharmaceuticals, Inc. | 970.00M | 6.86% | 4,843,827 | 41.47M |
| 172 | SGP | SpyGlass Pharma, Inc. | 959.62M | 2.61% | 171,654 | - |
| 173 | SLBT | SL Science Holding Limited | 958.05M | -2.33% | 28,261 | 3.27M |
| 174 | SLDB | Solid Biosciences Inc. | 956.45M | 4.45% | 1,305,487 | - |
| 175 | ATTO | Attovia Therapeutics, Inc. | 950.92M | -2.21% | 317,688 | 1.80M |
| 176 | IMMX | Immix Biopharma, Inc. | 917.85M | 2.89% | 948,505 | - |
| 177 | RIGL | Rigel Pharmaceuticals, Inc. | 911.95M | 3.67% | 242,877 | 276.79M |
| 178 | CADL | Candel Therapeutics, Inc. | 906.74M | 5.71% | 882,043 | - |
| 179 | ARDX | Ardelyx, Inc. | 902.06M | 3.43% | 3,988,940 | 450.89M |
| 180 | AVTX | Avalo Therapeutics, Inc. | 885.43M | 2.10% | 585,526 | 59.00K |
| 181 | TBPH | Theravance Biopharma, Inc. | 884.18M | -0.12% | 6,187,420 | 104.31M |
| 182 | FDMT | 4D Molecular Therapeutics, Inc. | 877.28M | 4.20% | 936,969 | 92.01M |
| 183 | FTH | Faeth Therapeutics, Inc. | 863.07M | 0.33% | 633,533 | - |
| 184 | WVE | Wave Life Sciences, Inc. | 857.16M | 2.23% | 2,578,113 | 65.37M |
| 185 | ETRA | Electra Therapeutics, Inc. | 854.89M | -2.16% | 439,703 | - |
| 186 | OLMA | Olema Pharmaceuticals, Inc. | 843.48M | 0.10% | 1,490,505 | - |
| 187 | ACRS | Aclaris Therapeutics, Inc. | 841.98M | 2.69% | 2,879,401 | 8.22M |
| 188 | GERN | Geron Corporation | 841.64M | 0.77% | 6,215,162 | 204.56M |
| 189 | ACHV | Achieve Life Sciences, Inc. | 835.57M | 0.87% | 1,674,963 | - |
| 190 | IVA | Inventiva S.A. | 828.70M | - | 2,556,229 | 7.94M |
| 191 | DSGN | Design Therapeutics, Inc. | 823.57M | 4.86% | 506,539 | - |
| 192 | CLYM | Climb Bio, Inc. | 816.17M | 4.18% | 930,127 | - |
| 193 | GYRE | Gyre Therapeutics, Inc. | 794.19M | 0.81% | 227,129 | 109.82M |
| 194 | ANNX | Annexon, Inc. | 792.44M | -0.95% | 2,000,239 | - |
| 195 | PHAR | Pharming Group N.V. | 781.08M | 4.16% | 51,291 | 366.48M |
| 196 | BLSM | BlossomHill Therapeutics, Inc. | 773.75M | -5.78% | 246,876 | - |
| 197 | VSTM | Verastem, Inc. | 758.02M | 4.76% | 3,056,452 | 87.53M |
| 198 | NVCT | Nuvectis Pharma, Inc. | 749.38M | 4.64% | 123,965 | - |
| 199 | SLN | Silence Therapeutics plc | 739.97M | 0.33% | 382,052 | 615.00K |
| 200 | DBVT | DBV Technologies S.A. | 724.63M | 4.38% | 281,997 | 5.04M |
| 201 | MDXG | MiMedx Group, Inc. | 718.60M | 2.49% | 1,032,049 | 355.17M |
| 202 | OABI | OmniAb, Inc. | 715.32M | 7.42% | 1,375,229 | 38.46M |
| 203 | CBIO | Crescent Biopharma, Inc. | 703.65M | 1.17% | 257,617 | 11.88M |
| 204 | SGMT | Sagimet Biosciences Inc. | 689.34M | 2.69% | 874,193 | - |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 687.66M | -0.77% | 601,196 | 136.07M |
| 206 | NGNE | Neurogene Inc. | 672.38M | 3.16% | 1,223,248 | 925.00K |
| 207 | AURA | Aura Biosciences, Inc. | 668.90M | 1.42% | 601,581 | - |
| 208 | ALT | Altimmune, Inc. | 663.31M | 4.28% | 4,003,284 | 31.00K |
| 209 | OCS | Oculis Holding AG | 661.15M | 5.62% | 206,769 | 1.45M |
| 210 | STTK | Shattuck Labs, Inc. | 652.36M | 6.38% | 1,459,315 | 1.00M |
| 211 | MNPR | Monopar Therapeutics Inc. | 648.60M | 0.95% | 136,009 | - |
| 212 | CTMX | CytomX Therapeutics, Inc. | 640.62M | 6.52% | 7,922,968 | 18.30M |
| 213 | DNA | Ginkgo Bioworks Holdings, Inc. | 630.98M | 17.42% | 3,334,099 | 132.42M |
| 214 | PRME | Prime Medicine, Inc. | 629.78M | 10.97% | 2,725,339 | 4.07M |
| 215 | PHAT | Phathom Pharmaceuticals, Inc. | 616.38M | 4.16% | 1,953,565 | 239.66M |
| 216 | VALN | Valneva SE | 614.36M | -0.45% | 14,207 | 163.30M |
| 217 | DRUG | Bright Minds Biosciences Inc. | 607.73M | 2.03% | 65,268 | - |
| 218 | CRMD | CorMedix Inc. | 606.41M | 0.13% | 788,927 | 462.25M |
| 219 | MPLT | MapLight Therapeutics, Inc. | 603.55M | -0.37% | 411,387 | - |
| 220 | ALLO | Allogene Therapeutics, Inc. | 590.79M | 1.18% | 5,237,474 | 4.64M |
| 221 | EPRX | Eupraxia Pharmaceuticals Inc. | 565.96M | -0.69% | 781,668 | - |
| 222 | AGMB | AgomAb Therapeutics NV | 565.86M | -1.79% | 49,390 | - |
| 223 | ARVN | Arvinas, Inc. | 556.44M | 2.53% | 685,448 | 316.70M |
| 224 | PROK | ProKidney Corp. | 553.25M | 3.10% | 588,523 | 818.00K |
| 225 | CAPR | Capricor Therapeutics, Inc. | 543.02M | 4.94% | 2,499,554 | 11.13M |
| 226 | AUTL | Autolus Therapeutics plc | 540.31M | 4.64% | 1,569,963 | 117.39M |
| 227 | OVID | Ovid Therapeutics Inc. | 539.02M | 1.85% | 3,743,696 | 1.58M |
| 228 | RGNX | REGENXBIO Inc. | 538.01M | 3.43% | 1,202,481 | 174.48M |
| 229 | INDP | Indaptus Therapeutics, Inc. | 531.64M | 29.13% | 1,270,092 | - |
| 230 | SCTX | Scribe Therapeutics Inc. | 531.41M | 0.07% | 584,804 | 33.30M |
| 231 | ASMB | Assembly Biosciences, Inc. | 518.18M | 0.04% | 1,070,125 | 74.85M |
| 232 | TECX | Tectonic Therapeutic, Inc. | 518.06M | -0.49% | 188,604 | - |
| 233 | ENTX | Entera Bio Ltd. | 515.96M | 0.68% | 613,718 | 42.00K |
| 234 | PBYI | Puma Biotechnology, Inc. | 506.91M | 2.40% | 360,724 | 231.24M |
| 235 | CTNM | Contineum Therapeutics, Inc. | 504.12M | -1.11% | 770,298 | - |
| 236 | PRLD | Prelude Therapeutics Incorporated | 499.53M | 3.19% | 424,587 | 22.42M |
| 237 | EIKN | Eikon Therapeutics, Inc. | 486.40M | 1.70% | 430,662 | - |
| 238 | KYTX | Kyverna Therapeutics, Inc. | 464.44M | 5.48% | 836,803 | - |
| 239 | PRTA | Prothena Corporation plc | 461.52M | 5.64% | 445,501 | 54.53M |
| 240 | TTRX | Turn Therapeutics Inc. | 455.46M | -0.33% | 122,650 | - |
| 241 | AVIR | Atea Pharmaceuticals, Inc. | 452.35M | 3.87% | 237,550 | - |
| 242 | RLMD | Relmada Therapeutics, Inc. | 452.28M | 1.92% | 662,655 | - |
| 243 | EDIT | Editas Medicine, Inc. | 448.45M | 3.18% | 2,295,647 | 47.01M |
| 244 | SPRY | ARS Pharmaceuticals, Inc. | 445.52M | 2.99% | 1,268,338 | 116.93M |
| 245 | ZURA | Zura Bio Limited | 432.19M | 0.22% | 2,150,458 | - |
| 246 | IRD | Opus Genetics, Inc. | 429.29M | -1.15% | 1,172,556 | 9.86M |
| 247 | CABA | Cabaletta Bio, Inc. | 423.86M | 1.63% | 5,313,653 | - |
| 248 | RZLT | Rezolute, Inc. | 422.05M | 3.32% | 928,648 | - |
| 249 | IKT | Inhibikase Therapeutics, Inc. | 420.59M | 5.00% | 468,655 | 1.00 |
| 250 | DMAC | DiaMedica Therapeutics Inc. | 419.54M | 7.16% | 312,078 | - |
| 251 | GALT | Galectin Therapeutics Inc. | 417.52M | 4.55% | 258,069 | - |
| 252 | ARCT | Arcturus Therapeutics Holdings Inc. | 408.72M | -2.11% | 1,074,432 | 29.37M |
| 253 | CCCC | C4 Therapeutics, Inc. | 407.21M | 0.30% | 1,358,019 | 35.04M |
| 254 | LRMR | Larimar Therapeutics, Inc. | 398.74M | -0.26% | 702,938 | - |
| 255 | ARTV | Artiva Biotherapeutics, Inc. | 395.52M | 3.32% | 437,977 | 251.00K |
| 256 | VOGX | Vogenx, Inc. | 394.70M | -9.93% | 164,803 | - |
| 257 | AGEN | Agenus Inc. | 391.68M | 4.44% | 994,137 | 132.69M |
| 258 | VTVT | vTv Therapeutics Inc. | 386.41M | -0.64% | 11,170 | 36.84M |
| 259 | FENC | Fennec Pharmaceuticals Inc. | 386.09M | 0.92% | 91,699 | 59.22M |
| 260 | BNTC | Benitec Biopharma Inc. | 381.97M | 0.64% | 88,930 | - |
| 261 | OBIO | Orchestra BioMed Holdings, Inc. | 373.85M | -0.48% | 343,050 | 31.98M |
| 262 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 373.61M | - | 509,117 | - |
| 263 | RCKT | Rocket Pharmaceuticals, Inc. | 367.74M | 2.45% | 1,076,715 | - |
| 264 | ENTA | Enanta Pharmaceuticals, Inc. | 361.74M | 2.56% | 164,646 | 65.26M |
| 265 | OCGN | Ocugen, Inc. | 352.67M | 0.97% | 5,713,353 | 4.58M |
| 266 | EYPT | EyePoint, Inc. | 350.88M | 1.24% | 4,463,693 | 2.79M |
| 267 | EVMN | Evommune, Inc. | 348.40M | 1.59% | 573,819 | 10.00M |
| 268 | IPSC | Century Therapeutics, Inc. | 342.23M | 2.16% | 414,144 | 109.16M |
| 269 | XFOR | X4 Pharmaceuticals, Inc. | 340.07M | -1.86% | 923,763 | 15.85M |
| 270 | LXEO | Lexeo Therapeutics, Inc. | 333.91M | -0.25% | 3,092,290 | - |
| 271 | ABEO | Abeona Therapeutics Inc. | 332.81M | 2.65% | 1,020,047 | 25.52M |
| 272 | SABS | SAB Biotherapeutics, Inc. | 318.45M | 3.24% | 738,965 | 114.70K |
| 273 | VNDA | Vanda Pharmaceuticals Inc. | 315.01M | 0.97% | 617,871 | 215.72M |
| 274 | QTTB | Q32 Bio Inc. | 314.66M | 0.96% | 387,173 | 53.74M |
| 275 | FATE | Fate Therapeutics, Inc. | 309.14M | 1.98% | 1,664,045 | 6.49M |
| 276 | IFRX | InflaRx N.V. | 306.53M | -1.89% | 571,272 | -11.54K |
| 277 | UPB | Upstream Bio, Inc. | 300.69M | 2.23% | 360,533 | 3.16M |
| 278 | IMRX | Immuneering Corporation | 298.26M | 3.83% | 590,424 | - |
| 279 | CUVL | Clinuvel Pharmaceuticals Limited | 295.69M | - | 4,593 | 65.05M |
| 280 | PALI | Palisade Bio, Inc. | 294.52M | - | 4,984,154 | 500.00K |
| 281 | VCRE | Vicore Pharma Holding AB (publ) | 293.02M | -0.39% | 19,747 | 412.09K |
| 282 | FULC | Fulcrum Therapeutics, Inc. | 292.98M | 1.05% | 978,964 | 80.00M |
| 283 | ZNTL | Zentalis Pharmaceuticals, Inc. | 291.59M | 1.65% | 956,313 | 26.87M |
| 284 | GLSI | Greenwich LifeSciences, Inc. | 285.93M | 4.73% | 122,882 | - |
| 285 | IVVD | Invivyd, Inc. | 284.15M | -5.49% | 8,439,253 | 58.37M |
| 286 | PYXS | Pyxis Oncology, Inc. | 279.83M | 5.17% | 480,074 | 11.04M |
| 287 | LYEL | Lyell Immunopharma, Inc. | 273.23M | 2.01% | 211,514 | 27.00K |
| 288 | SION | Sionna Therapeutics, Inc. | 272.18M | 0.33% | 1,693,924 | - |
| 289 | ACIU | AC Immune SA | 271.44M | 2.82% | 78,091 | 21.67M |
| 290 | PRQR | ProQR Therapeutics N.V. | 268.13M | 2.15% | 433,854 | 21.05M |
| 291 | STRO | Sutro Biopharma, Inc. | 267.45M | -1.35% | 246,240 | 45.70M |
| 292 | YARW | Yarrow Bioscience, Inc. | 266.85M | 1.34% | 104,765 | - |
| 293 | LCTX | Lineage Cell Therapeutics, Inc. | 263.02M | 2.97% | 847,526 | 13.08M |
| 294 | MGNX | MacroGenics, Inc. | 262.44M | - | 377,360 | 175.14M |
| 295 | BCYC | Bicycle Therapeutics plc | 261.07M | 2.75% | 554,654 | 61.21M |
| 296 | CAMP | Camp4 Therapeutics Corporation | 260.43M | -0.48% | 161,168 | 4.22M |
| 297 | FHTX | Foghorn Therapeutics Inc. | 251.79M | 2.17% | 328,886 | 36.74M |
| 298 | RNAC | Cartesian Therapeutics, Inc. | 244.46M | 1.76% | 161,751 | 1.48M |
| 299 | TRDA | Entrada Therapeutics, Inc. | 241.94M | 1.05% | 195,517 | 4.69M |
| 300 | CGEN | Compugen Ltd. | 235.86M | 2.26% | 230,978 | 74.00M |
| 301 | ELDN | Eledon Pharmaceuticals, Inc. | 235.08M | 7.43% | 2,095,648 | - |
| 302 | KROS | Keros Therapeutics, Inc. | 232.57M | 2.18% | 189,818 | 15.01M |
| 303 | WHWK | Whitehawk Therapeutics, Inc. | 230.32M | - | 149,065 | 7.15M |
| 304 | AVXL | Anavex Life Sciences Corp. | 228.96M | 2.92% | 639,993 | - |
| 305 | PLX | Protalix BioTherapeutics, Inc. | 228.82M | 3.27% | 854,902 | 80.62M |
| 306 | CUE | Cue Biopharma, Inc. | 224.47M | 9.30% | 1,205,816 | 37.66M |
| 307 | ALEC | Alector, Inc. | 224.43M | 4.15% | 1,464,201 | 13.86M |
| 308 | CMPX | Compass Therapeutics, Inc. | 223.31M | -31.87% | 27,202,789 | 850.00K |
| 309 | NGEN | NervGen Pharma Corp. | 222.03M | 3.77% | 223,722 | - |
| 310 | ALXO | ALX Oncology Holdings Inc. | 221.24M | -3.61% | 652,789 | - |
| 311 | TARA | Protara Therapeutics, Inc. | 217.47M | 4.84% | 2,893,290 | - |
| 312 | ADAG | Adagene Inc. | 216.87M | 0.62% | 226,328 | 9.29M |
| 313 | NKTX | Nkarta, Inc. | 211.29M | 2.43% | 415,563 | - |
| 314 | SRZN | Surrozen, Inc. | 206.86M | 6.47% | 89,808 | 11.51M |
| 315 | PEPG | PepGen Inc. | 206.39M | 4.93% | 523,680 | - |
| 316 | CHRS | Coherus Oncology, Inc. | 200.85M | -5.11% | 4,537,053 | 50.94M |
| 317 | YDES | YD Bio Limited | 199.74M | 7.22% | 390,524 | 1.24M |
| 318 | SLGL | Sol-Gel Technologies Ltd. | 199.55M | 2.82% | 79,722 | 1.80M |
| 319 | VRXA | Veraxa Biotech AG | 199.39M | -0.70% | 59,719 | 29.54K |
| 320 | DTIL | Precision BioSciences, Inc. | 198.46M | 10.62% | 431,582 | 45.06M |
| 321 | ORMP | Oramed Pharmaceuticals Inc. | 197.59M | 1.06% | 145,231 | 2.00M |
| 322 | CNTN | Canton Strategic Holdings, Inc. | 195.22M | 0.41% | 679,346 | 1.50M |
| 323 | ACOG | Alpha Cognition Inc. | 194.91M | -0.22% | 125,728 | 15.26M |
| 324 | VYGR | Voyager Therapeutics, Inc. | 193.48M | 1.95% | 341,563 | 34.46M |
| 325 | ABOS | Acumen Pharmaceuticals, Inc. | 191.64M | 2.32% | 568,359 | - |
| 326 | MSLE | Satellos Bioscience Inc. | 191.24M | -3.38% | 26,800 | - |
| 327 | NBP | NovaBridge Biosciences | 184.44M | -1.24% | 464,890 | - |
| 328 | ANTX | AN2 Therapeutics, Inc. | 182.27M | -2.62% | 191,681 | - |
| 329 | NERV | Minerva Neurosciences, Inc. | 181.92M | 3.39% | 123,932 | - |
| 330 | TNXP | Tonix Pharmaceuticals Holding Corp. | 181.63M | -1.21% | 586,134 | 29.10M |
| 331 | MDWD | MediWound Ltd. | 180.10M | 4.81% | 80,694 | 11.86M |
| 332 | MENS | Jyong Biotech Ltd. | 176.68M | 10.70% | 121,284 | - |
| 333 | OTLK | Outlook Therapeutics, Inc. | 169.49M | 1.44% | 2,864,500 | -1.16M |
| 334 | IPHA | Innate Pharma S.A. | 164.91M | -3.23% | 55,822 | 11.21M |
| 335 | HUMA | Humacyte, Inc. | 161.90M | -1.22% | 3,469,806 | 2.12M |
| 336 | MOLN | Molecular Partners AG | 158.57M | 6.77% | 1,008 | 856.30K |
| 337 | RNA | Atrium Therapeutics, Inc. | 157.71M | 0.33% | 241,278 | 35.84M |
| 338 | ARMP | Armata Pharmaceuticals, Inc. | 156.16M | -1.41% | 128,357 | 5.54M |
| 339 | TNYA | Tenaya Therapeutics, Inc. | 152.97M | 1.25% | 1,226,633 | 1.34M |
| 340 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 152.31M | 2.94% | 453,845 | - |
| 341 | KRRO | Korro Bio, Inc. | 152.26M | 3.61% | 213,478 | 2.38M |
| 342 | CDXS | Codexis, Inc. | 152.21M | 0.72% | 1,039,817 | 77.68M |
| 343 | KZIA | Kazia Therapeutics Limited | 149.64M | 2.54% | 321,132 | 1.27M |
| 344 | IMUX | Immunic, Inc. | 147.91M | 0.09% | 430,739 | - |
| 345 | NMRA | Neumora Therapeutics, Inc. | 146.28M | 12.53% | 3,211,891 | - |
| 346 | SPRB | Spruce Biosciences, Inc. | 143.67M | -6.91% | 140,921 | 697.00K |
| 347 | CRBU | Caribou Biosciences, Inc. | 143.66M | 3.08% | 1,217,330 | 10.04M |
| 348 | NRXP | NRx Pharmaceuticals, Inc. | 143.63M | 0.91% | 495,041 | 3.39M |
| 349 | MNOV | MediciNova, Inc. | 142.74M | -12.12% | 2,478,642 | 920.48K |
| 350 | UNCY | Unicycive Therapeutics, Inc. | 138.16M | 3.98% | 588,055 | - |
| 351 | ENGN | enGene Therapeutics Inc. | 137.38M | 4.59% | 1,066,302 | - |
| 352 | HURA | TuHURA Biosciences, Inc. | 135.74M | -2.29% | 251,786 | - |
| 353 | INO | Inovio Pharmaceuticals, Inc. | 133.38M | 4.03% | 2,925,294 | 65.34K |
| 354 | MIST | Milestone Pharmaceuticals Inc. | 129.78M | 0.35% | 1,720,804 | 2.34M |
| 355 | LENZ | LENZ Therapeutics, Inc. | 129.77M | 1.23% | 511,018 | 21.48M |
| 356 | NAUT | Nautilus Biotechnology, Inc. | 127.18M | 4.68% | 606,824 | 190.00K |
| 357 | AARD | Aardvark Therapeutics, Inc. | 125.84M | 3.23% | 101,317 | - |
| 358 | OKUR | OnKure Therapeutics, Inc. | 125.54M | 1.31% | 200,808 | - |
| 359 | COYA | Coya Therapeutics, Inc. | 124.33M | 7.07% | 334,121 | 8.02M |
| 360 | CNXU | Conexeu Sciences Inc. | 124.11M | -7.37% | 158,301 | - |
| 361 | BMEA | Biomea Fusion, Inc. | 123.22M | -0.58% | 2,337,434 | - |
| 362 | EQ | Equillium, Inc. | 122.38M | 1.85% | 3,072,082 | 4.39M |
| 363 | PMN | ProMIS Neurosciences, Inc. | 121.78M | -0.37% | 94,202 | - |
| 364 | CBUS | Cibus, Inc. | 121.52M | 1.92% | 135,782 | 4.35M |
| 365 | GNLX | Genelux Corporation | 116.96M | 1.95% | 161,803 | 8.00K |
| 366 | CLLS | Cellectis S.A. | 115.71M | 3.31% | 76,318 | 63.82M |
| 367 | TLSA | Tiziana Life Sciences Ltd | 115.07M | -1.63% | 624,152 | - |
| 368 | VANI | Vivani Medical, Inc. | 114.56M | 2.42% | 175,676 | - |
| 369 | PMVP | PMV Pharmaceuticals, Inc. | 114.02M | 2.37% | 316,918 | - |
| 370 | BDTX | Black Diamond Therapeutics, Inc. | 113.76M | 1.54% | 744,203 | 70.00M |
| 371 | TENX | Tenax Therapeutics, Inc. | 111.13M | 3.19% | 2,189,188 | - |
| 372 | PYPD | PolyPid Ltd. | 110.70M | 5.42% | 127,010 | - |
| 373 | RANI | Rani Therapeutics Holdings, Inc. | 108.44M | -1.46% | 652,027 | 4.88M |
| 374 | PLYX | Polaryx Therapeutics, Inc. | 107.17M | 0.47% | 25,191 | - |
| 375 | CRDF | Cardiff Oncology, Inc. | 103.47M | -2.92% | 518,456 | 508.00K |
| 376 | SEER | Seer, Inc. | 102.99M | - | 69,211 | 14.22M |
| 377 | ACET | Adicet Bio, Inc. | 98.44M | 2.41% | 87,831 | - |
| 378 | ANIX | Anixa Biosciences, Inc. | 96.99M | 3.33% | 434,621 | - |
| 379 | CGTX | Cognition Therapeutics, Inc. | 93.32M | -1.87% | 332,337 | - |
| 380 | ACRV | Acrivon Therapeutics, Inc. | 92.13M | 6.97% | 572,485 | - |
| 381 | NRXS | NeurAxis, Inc. | 91.80M | 2.38% | 149,635 | 5.32M |
| 382 | ONCY | Oncolytics Biotech Inc. | 90.95M | -6.92% | 2,075,160 | - |
| 383 | ICCC | ImmuCell Corporation | 90.73M | -1.38% | 36,073 | 30.68M |
| 384 | RLYB | Rallybio Corporation | 89.85M | -0.06% | 7,620 | 646.00K |
| 385 | ATRA | Atara Biotherapeutics, Inc. | 89.64M | -4.80% | 27,266 | 6.19M |
| 386 | PTHS | Pelthos Therapeutics Inc. | 88.97M | 0.39% | 43,900 | 43.30M |
| 387 | GUTS | Fractyl Health, Inc. | 88.03M | -3.27% | 1,119,098 | 3.00K |
| 388 | TELO | Telomir Pharmaceuticals, Inc. | 85.97M | 0.81% | 103,552 | - |
| 389 | NTHI | NeOnc Technologies Holdings, Inc. | 85.76M | 3.60% | 146,422 | 39.99K |
| 390 | IBIO | iBio, Inc. | 85.53M | 5.56% | 2,093,406 | 100.00K |
| 391 | GANX | Gain Therapeutics, Inc. | 85.11M | 5.98% | 692,700 | - |
| 392 | ALDX | Aldeyra Therapeutics, Inc. | 84.16M | 3.33% | 429,895 | - |
| 393 | MAIA | MAIA Biotechnology, Inc. | 83.33M | 3.01% | 940,373 | - |
| 394 | NTRB | Nutriband Inc. | 82.17M | -13.00% | 319,604 | 1.62M |
| 395 | FBIO | Fortress Biotech, Inc. | 81.71M | 1.66% | 199,727 | 68.47M |
| 396 | OSTX | OS Therapies Incorporated | 81.64M | 1.72% | 600,391 | - |
| 397 | VRCA | Verrica Pharmaceuticals Inc. | 81.08M | 5.12% | 65,141 | 30.32M |
| 398 | SPRO | Spero Therapeutics, Inc. | 79.20M | 19.30% | 7,764,493 | 47.00M |
| 399 | KLRS | Kalaris Therapeutics, Inc. | 77.13M | -0.15% | 29,136 | - |
| 400 | RNXT | RenovoRx, Inc. | 76.72M | 1.80% | 383,949 | 1.98M |
| 401 | CNTB | Connect Biopharma Holdings Limited | 76.51M | -7.95% | 1,223,618 | 2.95M |
| 402 | CING | Cingulate Inc. | 74.82M | -1.63% | 78,625 | - |
| 403 | CSBR | Champions Oncology, Inc. | 73.63M | 0.57% | 11,310 | 60.66M |
| 404 | GOSS | Gossamer Bio, Inc. | 71.43M | 3.63% | 195,829 | 53.29M |
| 405 | BSEM | BioStem Technologies, Inc. | 71.04M | -9.55% | 129,672 | 34.59M |
| 406 | OKYO | OKYO Pharma Limited | 70.85M | 1.50% | 98,710 | - |
| 407 | PLRX | Pliant Therapeutics, Inc. | 70.59M | 2.70% | 326,685 | - |
| 408 | HYFT | MindWalk Holdings Corp. | 69.54M | 0.68% | 152,985 | 11.57M |
| 409 | RNTX | Rein Therapeutics Inc. | 68.56M | 0.03% | 87,140 | - |
| 410 | ELOX | Eloxx Pharmaceuticals, Inc. | 67.53M | -2.68% | 15,821 | - |
| 411 | ALPS | Alps Group Inc | 66.54M | -0.03% | 61,266 | 3.74M |
| 412 | XBIT | XBiotech Inc. | 66.46M | - | 9,100 | - |
| 413 | ATHE | Alterity Therapeutics Limited | 65.88M | - | 11,825 | 2.50M |
| 414 | BOLD | Boundless Bio, Inc. | 65.51M | 1.77% | 30,246 | - |
| 415 | HYPD | Hyperion DeFi, Inc. | 62.00M | 3.64% | 548,957 | 1.40M |
| 416 | INKT | MiNK Therapeutics, Inc. | 61.80M | -1.14% | 8,581 | - |
| 417 | INMB | INmune Bio Inc. | 59.95M | -5.68% | 375,456 | 50.00K |
| 418 | XLO | Xilio Therapeutics, Inc. | 59.48M | 0.22% | 6,878 | 64.09M |
| 419 | SER | Serina Therapeutics, Inc. | 58.68M | - | 23,847 | 130.00K |
| 420 | EXOZ | eXoZymes, Inc. | 57.45M | 0.81% | 9,510 | -700.00 |
| 421 | LONA | LeonaBio, Inc. | 57.00M | -4.42% | 34,851 | - |
| 422 | IBO | Impact BioMedical Inc. | 56.89M | -5.02% | 12,266 | 35.00K |
| 423 | HRTX | Heron Therapeutics, Inc. | 56.77M | 10.74% | 3,870,636 | 151.18M |
| 424 | CLNN | Clene Inc. | 56.28M | -3.52% | 135,774 | 197.00K |
| 425 | IMA | ImageneBio, Inc. | 55.05M | 0.83% | 8,464 | 800.00K |
| 426 | EDSA | Edesa Biotech, Inc. | 54.99M | -0.97% | 26,116 | - |
| 427 | ANVS | Annovis Bio, Inc. | 53.68M | 5.88% | 1,214,830 | - |
| 428 | APLM | Apollomics, Inc. | 52.09M | -0.79% | 3,229 | 8.84M |
| 429 | DWTX | Dogwood Therapeutics, Inc. | 51.33M | -5.63% | 128,220 | - |
| 430 | PDSB | PDS Biotechnology Corporation | 50.93M | 8.09% | 24,749,958 | - |
| 431 | TVGN | Tevogen Inc. | 50.86M | 5.11% | 2,795 | - |
| 432 | MREO | Mereo BioPharma Group plc | 50.51M | 9.03% | 2,320,591 | 500.00K |
| 433 | FLNA | Filana Therapeutics, Inc. | 49.76M | 39.28% | 94,301,465 | - |
| 434 | ELTX | Elicio Therapeutics, Inc. | 49.15M | -2.09% | 404,041 | - |
| 435 | TIL | Instil Bio, Inc. | 48.36M | 0.85% | 23,894 | - |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 47.72M | 0.20% | 375,929 | 21.00M |
| 437 | GRCE | Grace Therapeutics, Inc. | 45.02M | 1.90% | 71,117 | - |
| 438 | LITS | Lite Strategy, Inc. | 44.23M | 1.56% | 610,746 | - |
| 439 | MGX | Metagenomi Therapeutics, Inc. | 43.07M | 1.79% | 165,230 | 13.56M |
| 440 | IMMP | Immutep Limited | 42.94M | -2.81% | 149,582 | 13.79M |
| 441 | VERU | Veru Inc. | 42.63M | 2.46% | 121,369 | 16.89M |
| 442 | KPTI | Karyopharm Therapeutics Inc. | 41.28M | -2.15% | 986,901 | 146.62M |
| 443 | MCRB | Seres Therapeutics, Inc. | 39.96M | -1.23% | 35,743 | 1.88M |
| 444 | CRVO | CervoMed Inc. | 38.25M | 4.98% | 260,726 | 331.30K |
| 445 | ATNM | Actinium Pharmaceuticals, Inc. | 36.79M | -2.50% | 54,493 | 35.09M |
| 446 | CNTX | Context Therapeutics Inc. | 35.75M | 3.87% | 539,300 | - |
| 447 | BCTX | BriaCell Therapeutics Corp. | 35.50M | -1.45% | 188,574 | - |
| 448 | ALGS | Aligos Therapeutics, Inc. | 35.47M | 3.46% | 75,687 | 31.52M |
| 449 | ATYR | aTyr Pharma, Inc. | 34.96M | -4.40% | 1,335,764 | 190.00K |
| 450 | NNVC | NanoViricides, Inc. | 34.85M | -9.47% | 1,289,555 | - |
| 451 | CELU | Celularity Inc. | 34.16M | -4.84% | 154,731 | 26.55M |
| 452 | QNRX | Quoin Pharmaceuticals, Ltd. | 33.68M | 1.59% | 29,289 | - |
| 453 | QNCX | Quince Therapeutics, Inc. | 31.88M | 1.13% | 24,000 | - |
| 454 | BYSI | BeyondSpring Inc. | 30.44M | 0.04% | 15,701 | 1.88M |
| 455 | ABVC | ABVC BioPharma, Inc. | 30.07M | 0.87% | 91,648 | 797.92K |
| 456 | RNAZ | TransCode Therapeutics, Inc. | 29.97M | 0.57% | 59,515 | - |
| 457 | QNTM | Quantum BioPharma Ltd. | 29.92M | 2.49% | 193,807 | - |
| 458 | CVM | CEL-SCI Corporation | 29.90M | 1.80% | 133,848 | - |
| 459 | KYNB | Kyntra Bio, Inc. | 29.48M | 1.11% | 22,496 | 4.62M |
| 460 | IGC | IGC Pharma, Inc. | 29.26M | 3.28% | 610,953 | 1.11M |
| 461 | GRDX | GridAI Technologies Corp. | 27.55M | 14.41% | 77,631 | - |
| 462 | EVAX | Evaxion A/S | 27.27M | 1.87% | 32,400 | 7.49M |
| 463 | PLRZ | Polyrizon Ltd. | 25.61M | -2.20% | 6,531 | - |
| 464 | RADX | Radiopharm Theranostics Limited | 24.66M | 2.48% | 33,431 | 9.34M |
| 465 | TCRX | TScan Therapeutics, Inc. | 24.05M | 7.32% | 918,453 | 7.11M |
| 466 | NXTC | NextCure, Inc. | 23.71M | -5.13% | 156,970 | - |
| 467 | PBM | Psyence Biomedical Ltd. | 23.27M | -6.44% | 179,233 | - |
| 468 | COCP | Cocrystal Pharma, Inc. | 22.92M | - | 69,025 | 330.00K |
| 469 | ATOS | Atossa Therapeutics, Inc. | 22.55M | 0.44% | 129,526 | - |
| 470 | ESLA | Estrella Immunopharma, Inc. | 21.10M | -3.42% | 62,630 | - |
| 471 | CLRB | Cellectar Biosciences, Inc. | 21.08M | -5.11% | 161,241 | - |
| 472 | TVRD | Tvardi Therapeutics, Inc. | 20.94M | -2.48% | 128,182 | - |
| 473 | JSPR | Jasper Therapeutics, Inc. | 20.73M | 3.35% | 310,123 | - |
| 474 | MRKR | Marker Therapeutics, Inc. | 20.34M | 1.67% | 38,955 | 3.55M |
| 475 | NEUP | Neuphoria Therapeutics Inc. | 20.21M | 0.67% | 6,731 | 1.17M |
| 476 | AKTX | Akari Therapeutics, Plc | 19.57M | 7.14% | 78,483 | - |
| 477 | PTN | Palatin Technologies, Inc. | 19.47M | 0.49% | 41,664 | 12.88M |
| 478 | ACTU | Actuate Therapeutics, Inc. | 19.39M | -11.01% | 187,231 | - |
| 479 | LPCN | Lipocine Inc. | 17.81M | -3.57% | 64,404 | 1.57M |
| 480 | ALLR | Allarity Therapeutics, Inc. | 17.66M | -5.13% | 185,809 | 345.00K |
| 481 | NCEL | NewcelX Ltd. | 17.53M | 2.21% | 4,715 | - |
| 482 | LTRN | Lantern Pharma Inc. | 17.39M | -9.33% | 749,469 | - |
| 483 | CMMB | Chemomab Therapeutics Ltd. | 17.24M | -4.03% | 133,117 | - |
| 484 | KPRX | Kiora Pharmaceuticals, Inc. | 17.24M | 1.12% | 7,576 | 20.00K |
| 485 | KTTA | Pasithea Therapeutics Corp. | 17.18M | 0.72% | 164,995 | - |
| 486 | TPST | Tempest Therapeutics, Inc. | 16.54M | 29.23% | 3,611,074 | - |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 16.42M | 3.76% | 215,265 | 7.11M |
| 488 | PASG | Passage Bio, Inc. | 15.93M | 2.48% | 24,098 | - |
| 489 | BCDA | BioCardia, Inc. | 15.90M | -2.78% | 498,810 | 3.00K |
| 490 | ICU | SeaStar Medical Holding Corporation | 15.56M | -1.40% | 22,152 | 1.71M |
| 491 | CNSY | Cerenome, Inc. | 15.41M | 6.84% | 185,410 | 4.20M |
| 492 | DYAI | Dyadic International, Inc. | 14.58M | -0.25% | 194,895 | 3.80M |
| 493 | NIKI | Niki BioSolutions, Inc. | 14.16M | -3.02% | 65,009 | - |
| 494 | HIND | Vyome Holdings, Inc. | 13.69M | 1.04% | 24,778 | 129.73K |
| 495 | PLUR | Pluri Inc. | 13.58M | 2.80% | 31,917 | 1.02M |
| 496 | LSTA | Lisata Therapeutics, Inc. | 13.34M | -5.13% | 152,756 | 100.00K |
| 497 | NRSN | NeuroSense Therapeutics Ltd. | 13.27M | 8.46% | 28,550 | - |
| 498 | INTS | Intensity Therapeutics, Inc. | 13.09M | -0.25% | 14,777 | - |
| 499 | AEON | AEON Biopharma, Inc. | 13.07M | 3.15% | 398,526 | - |
| 500 | DARE | Daré Bioscience, Inc. | 13.00M | 4.94% | 245,720 | 1.37M |